<?xml version="1.0" encoding="UTF-8"?><Articles><Article><id>81</id><JournalTitle>COMPARISON OF THE EFFECTS OF SITAGLIPTIN AND ESTROGEN ON OVARIECTOMY INDUCED OSTEOPOROSIS IN RATS</JournalTitle><Abstract>Osteoporosis is one of the most prevalent bone diseases, especially among postmenopausal women. Diabetes
mellitus may be associated with the development osteoporosis. Hence, the purpose of the current study was to investigate the
effect of Sitagliptin (dipeptidyl peptidase-4 inhibitor) on induced osteoporosis in rats. The study was conducted on 40 female
rats that were divided into four equal groups: Group 1 served as sham operated group. Osteoporosis was induced by bilateral
ovariectomy in group 2 model group, group 3 estrogen replacement therapy (ERT) and group 4 sitagliptin treated for eight
weeks. Blood samples were collected at the end of experiment for measurement of serum alkaline phosphate (ALP), calcium
(Ca), phosphorus, osteocalcin and malondialdehyde (MDA). Urine samples were collected for measurement of urinary
deoxypyridoline/creatinine (DPY)/Cr). Tibias were removed for histopathological assessment. The current study showed a
significant increase in bone turnover in model group (increase urinary DPY/Cr, serum osteocalcin and serum ALP) when
compared to sham control group. Serum Ca was significantly decreased in model group when compared to sham control
group. There was a significant increase in oxidative stress marker (serum MDA) in model group when compared to sham
control group. Histopathological examination of tibial bones in model group showed significant osteopenic changes .Such
biochemical findings and tibial bones histopathological alterations induced by ovariectomy were significantly ameliorated by
administration of ERT and sitagliptin. Sitagliptin was found to be effective in reducing ovariectomy induced osteoporotic
changes. Thus, its use as an anti-diabetic agent in postmenauposal women should be encouraged.</Abstract><Email>aaaunis@yahoo.com</Email><articletype>Research</articletype><volume>5</volume><issue>1</issue><year>2015</year><keyword>Sitagliptin,Ovariectomy,Osteoporosis,Estrogen,Osteocalcin</keyword><AUTHORS>Amina Unis,Manal Hamza,Eman Abdelzaher</AUTHORS><afflication>Department of Pharmacology, Faculty of Medicine, University of Tabuk, Saudi Arabia,Department of Pharmacology, Faculty of Medicine, University of Tabuk, Saudi Arabia,Department of Pathology, Faculty of Medicine, Alexandria University, Egypt</afflication></Article></Articles>